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1. Introduction
Nowadays, influenza has vigorously evolved and mutated into different variations.
Many diseases are transmitted by virus particles. Influenza is caused by a virus that can be of
three different type $(A, B and C)$ . Among these types, the virus Ais epidemiologically the most
important for humans, since it can recombine its genes with those of strains circulating in
animal populations (birds, swine and horses). These relatively rare recombination give rise
every few decades to new viral subtypes via the so called antigenic shift mechanism. The new
subtypes, classified according to the antigenic and genetic nature of their surface
glycoprotiens $HA$ (hemagglutinin) and $NA$ (neuraminidase), are usually antigenically so
different from their ancestors to escape completely the defenses of the immune system of the
previously infected hosts. Consequently, every antigenic shift is associated potentially with
particularly severe pandemics.
Many mathematical models have been proposed in the literature to describe the
inter-pandemic ecology of influenza A in humans and used to be a valuable tool in the
understanding of immune response to infectious diseases which helps in clarifying and
testing hypotheses.
2. The model
This research represents a dynamical model of influenza virus replication in human
epithelial cells. For a spread of two diseases by effects of two type of influenza virus, we
developed a simplified dynamical model, which focuses on the control of the infections by
innate and adaptive immunity. Innate immunity is represent by interferon-induced
resistance to infection of respiratory epithelial cells and by removal of infected cells by effector
cells. Adaptive immunity is represented by virus specific antibodies. The model does not
include effects of time delays and assumed that antigenic shift is not included in this model.
This model is constructed as a system of 13 ordinary differential equations with 35
parameters characterizing the rate of various processes contributing to the course of disease.
The parameters are derived from published experimental data. Then we will show the
existence of solutions and bounded of solutions and investigate the behavior of systems.
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The general flow diagram is show in Fig.1, the proportion of susceptible $H(t)$, i.e.,
those cells do not have specific immune defenses against that particular strain; the fraction
$l_{1}(t),l_{2}(t)$of those individuals that are infected by virus A subtypel, 2 the two classes of those
cells resistant to infection by virus A subtype 1, 2 to that strain (i.e. recovered $R(t)$) $;D(t)$ is a
number of dead cells at time t. $V_{1}(t),$ $V_{2}(t)$ is a number of free virus A subtypel, 2 particles.
Fig.1 General flow diagram of the model.
$V_{1},V_{2}=1$ corresponds to $10^{10}$ particles/ml respiratory epithelial cells
The model of human immune response against influenza virus infection we consider
is a simplified model of population dynamics type with consists of the following interactions
(see fig.1). The epithehal cells of respiratory tract are assumed to be in one of five possible
states; healthy (fl), Infected $(l_{1}, l_{2})$ , dead $(D)$ or resistant $(R)$ to infection. The virus particles
12
$(V_{1}, V_{2})$ interact with healthy cells and infect them. Infected cells release new virus particles
upon their death. Proliferation of healthy cells causes regeneration and decrease in proportion
of dead cells.
These interactions were used in the construction of a system of 13 ordinary
differential equations describing the dynamics of the main variables, list in Tablel, which















The variable $D$ serves as a maker for issue damage and an indicator of the severity of disease.
We assume that $H+l_{1}+l_{2}+R+D=1.$
Infected cells by virus 1, 2 can be destroyed by the same effector cell. The production
rate of effector cells $(E)$ and plasma cells $(R$ are stimulated by the same APC $(M)$ .
And hence the system (1)$-(14)$ is dimensionless.
The interactions are based on clonal selection theory, mass-action kinetics,
characteristics of interactions and the birth-death balance of population of cells and
molecules.
Eq. (1), (2)of the system describes the rate of change of virus 1, 2 concentration
$V_{1},$ $V_{2}$ .It expresses the production rate of a viral particle by infected cells, rate of neutrahzation
of influenza Atype 1 and 2 virus by specific antibodies, the rate adsorption of viral particles
by uninfected cells, the natural decay of viral particle and the rate of nonspecific mucociliary
removal of virions supported by cough and other mechanisms.
Eq. (3) determines the time rate of change of healthy cells $H$ During recovery, new
healthy cells are generated as a result of proliferation of both healthy and resistant cells (the
offspring of resistant cells lose resistance) and hence the proliferation term is proportional to
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$(H+R)$ , and to $D$ (in a logistic fashion) since regeneration can only occur in the presence of
damage. Resistant cells $R$ gradually lose their resistance to infection and return into their
initial sensitive state (healthy state), which is characterized by the term $a_{R}R$ The terms
$\gamma_{HV1}V_{1}H,\gamma_{HV2}V_{2}H$ are the loss of healthy cells due to infection and the term $b_{HF}FH$
characterizes transition of the healthy cells into resistant state.
Eq. (4), (5)characterize the time rate of change of infected cells $l_{1},$ $l_{2}$ . The infection of
healthy cells and resistant cells by virus 1, 2 are described in the terms $\gamma_{HV1}V_{1}H,$ $\gamma_{HV2}V_{2}H.$
The term $b_{lE}El_{1},$ $b_{lE}El_{2}$ characterizes the destruction of infected cells by effector cells during
which no new virus produced. The last term indicates the natural death, damage by virus and
recovery of infected cells during which new virus particles are produced.
Eq. (6)establishes that the time rate of increase of activated APC $(M)$ is proportional
to the amount of the each virus and the amount of dead cells by each virus. The natural decay
of activated state ofAPC is represented by the last term.
Eq. (7) describes the time rate of change of interferons which depends on the
production rate of FbyAPC and by infected cells, on the rate of interferons which blinding
uninfected cells and the nonspecific decay of interferons represented by $a_{F}F$
Eq. (8) shows that resistant cells $R$ are induced from healthy cells and by resistant
cells $R$ gradually lose their resistance and convert back to healthy cells with finite lifetime.
The terms $b_{HF}FH$ characterize transition of the healthy cells into resistant $R$ state.
Eq. (9), (10) characterizes the rate of change of effector cells $E$ concentration and
takes into account the production rate of effector cells stimulated by APC and the destmction
rate of infected cells by effector cells. The terms $a_{E}(1-E)$ $a_{p}(1-P)$ in Eqs. (9), (10) are
approximated expressions for homeostatic maintenance of the levels of active effectors and
plasma cells. The first term in Eq. (10) characterizes the activation process of plasma cells
stimulated by APC.
Eq. (11) stands for the time rate of change of the concentration of antibodies
describing the production rate by plasma cells, the neutralization rate of free viral particles
by specific antibodies and the natural decay rate (last term)
Eq. (12), (13)The variable $S_{1},S_{2}$ represents the compatibility between antibodies
and the virus strain in an individual and ranges from $0$ (no compatibility) to 1 (maximal
compatibility) and can be interpreted as a measure of blinding affinity of the antibody and the
virus. The rate of increase of $S_{1},S_{2}$ is approximated by term $rP(1-S_{1}),rP(1-S_{2})$ which
accounts for two natural observation: (i) the increase in $S_{1},S_{2}$ are stimulated by plasma cells
and (ii) $S_{1},S_{2}$ cannot increase beyond 1. By adjusting the time evolution of $S_{1},S_{2}$ we may
observe how the course of the disease depends on the evolution of antigenic distance.
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We use software XPPAUT to run all simulations. The time courses of variables were obtained
by numerical integration using parameters provided in Table2. following clinical data.
$\infty. \mathcal{M}.$
$W$ $\omega.$
$V_{1}(0)=0.01,V_{2}(0)=0.S_{1}(0)=0.01, S_{2}(0)=0, r_{1}=000003, r_{2}=0$
$V_{1}(0)=0,V_{2}(0)=0.01,S_{1}(0)=0, S_{2}(0)=0.01, r_{1}=0, r_{2}=0.00001$
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$V_{1}(0)=0.01,V_{2}(0)=0.01,$ $S_{1}(0)=0.1,$ $S_{2}(0)=0.01,$ $r_{1}=0.00003,$ $r_{2}=0.00001$
$V_{1}(0)=0.7,V_{2}(0)=0.01,$ $S_{1}(0)=0.1,$ $S_{2}(0)=0.01,$ $r_{1}=0.00003,$ $r_{2}=0.00001$
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$\wedge,.$
$V_{1}(0)=0.01, V_{2}(0)=0.01, S_{1}(0)=0, S_{2}(0)=0.01, r_{1}=0, r_{2}=0.00001$
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